ArticleClinical and translational science2026

Population-Based Modeling to Predict Human PK/PD of TAK-500, an Anti-CCR2 Antibody-Drug Conjugate for First-in-Human Study in Cancer Patients.

Anitha Saravanakumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.